ЭПИВИР
Country: Belarus
Language: Russian
Source: Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)
Summary of Product characteristics
(SPC)
07-02-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Ламивудин
Available from:
GlaxoSmithKline Export Ltd, Великобритания
INN (International Name):
Lamivudine
Class:
оригинальное
Prescription type:
по рецепту
Manufactured by:
GlaxoSmithKline Inc., Канада
Therapeutic area:
Ламивудин
Product summary:
Нормативная документация: НД РБ 5039-2019; Номер разрешения НД: 6651
Authorization date:
2019-12-31
